Order Article Reprints

Yang H, Liu B, Liu D, Yang Z, Zhang S, Xu P, Xing Y, Kutschick I, Pfeffer S, Britzen-Laurent N, et al. Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer. Cancers. 2022; 14(13):3152. https://doi.org/10.3390/cancers14133152

Yang, Hai, Bin Liu, Dongxue Liu, Zhirong Yang, Shuman Zhang, Pengyan Xu, Yuming Xing, Isabella Kutschick, Susanne Pfeffer, Nathalie Britzen-Laurent, and et al. 2022. "Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer" Cancers 14, no. 13: 3152. https://doi.org/10.3390/cancers14133152

Yang, H., Liu, B., Liu, D., Yang, Z., Zhang, S., Xu, P., Xing, Y., Kutschick, I., Pfeffer, S., Britzen-Laurent, N., Grützmann, R., & Pilarsky, C. (2022). Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer. Cancers, 14(13), 3152. https://doi.org/10.3390/cancers14133152